MRK Merck PE ratio, current and historical analysis
As at Apr 1, 2025, the MRK stock has a PE ratio of 12.89. This is based on the current EPS of $6.76 and the stock price of $87.12 per share. A decrease of 75% has been recorded in the PE ratio compared to the average of 51.6 of the last four quarters.
MRK PE ratio history
The mean historical PE ratio of Merck over the last ten years is 56.59. The current 12.89 P/E ratio is 77% lower than the historical average. In the past ten years, MRK's PE ratio peaked in the Dec 2023 quarter at 778.71, with a price of $109.02 and an EPS of $0.14. The Sep 2015 quarter marked the lowest point at 13.1, with a price of $49.39 and an EPS of $3.77.
Merck PE ratio by year
Maximum annual increase: 3,922.26% in 2023
Maximum annual decrease: -98.11% in 2024
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 14.72 | -98.11% | $99.48 | $6.76 |
| 2023 | 778.71 | 3,922.26% | $109.02 | $0.14 |
| 2022 | 19.36 | 30.37% | $110.95 | $5.73 |
| 2021 | 14.85 | -49.35% | $76.64 | $5.16 |
| 2020 | 29.32 | 23.82% | $81.8 | $2.79 |
| 2019 | 23.68 | -27.47% | $90.95 | $3.84 |
| 2018 | 32.65 | -48.94% | $76.41 | $2.34 |
| 2017 | 63.94 | 54.22% | $56.27 | $0.88 |
| 2016 | 41.46 | 24.02% | $58.87 | $1.42 |
| 2015 | 33.43 | 142.6% | $52.82 | $1.58 |
| 2014 | 13.78 | -58.98% | $56.79 | $4.12 |
| 2013 | 33.59 | 66.53% | $50.05 | $1.49 |
| 2012 | 20.17 | 9.15% | $40.94 | $2.03 |
| 2011 | 18.48 | -85.64% | $37.7 | $2.04 |
| 2010 | 128.71 | 1,898.6% | $36.04 | $0.28 |
Merck PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 14.72 | -37.92% | $99.48 | $6.76 |
| Sep 2024 | 23.71 | 3.63% | $113.56 | $4.79 |
| Jun 2024 | 22.88 | -84.22% | $123.8 | $5.41 |
| Mar 2024 | 145 | -81.38% | $131.95 | $0.91 |
| Dec 2023 | 778.71 | 1,269.04% | $109.02 | $0.14 |
| Sep 2023 | 56.88 | -39.86% | $102.95 | $1.81 |
| Jun 2023 | 94.58 | 356.03% | $115.39 | $1.22 |
| Mar 2023 | 20.74 | 7.13% | $106.39 | $5.13 |
| Dec 2022 | 19.36 | 35.57% | $110.95 | $5.73 |
| Sep 2022 | 14.28 | 2.73% | $86.12 | $6.03 |
| Jun 2022 | 13.9 | -4.99% | $91.17 | $6.56 |
| Mar 2022 | 14.63 | -1.48% | $82.05 | $5.61 |
| Dec 2021 | 14.85 | -43.64% | $76.64 | $5.16 |
| Sep 2021 | 26.35 | -25.46% | $75.11 | $2.85 |
| Jun 2021 | 35.35 | 27.48% | $77.77 | $2.2 |
MRK average PE ratio chart
The current PE ratio of MRK is lower than the 3, 5 and 10-year averages.
MRK PE vs peers
MRK's PE ratio stands lower than its peer stocks LLY and JNJ. Merck is presently trading at a lower PE ratio (12.89) than its peer group average of 31.33.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MRK Merck & Co Inc | 12.89 | $220.07B |
| ABT Abbott Laboratories | 17.17 | $228.39B |
| PFE Pfizer Inc | 17.28 | $139.08B |
| NVS Novartis AG | 18.52 | $216.49B |
| JNJ Johnson & Johnson | 26.24 | $368.97B |
| AMGN Amgen Inc | 40.28 | $164.88B |
| LLY ELI LILLY & Co | 68.47 | $763.49B |
| BMY Bristol Myers Squibb Co | N/A | $120.85B |
| TEVA Teva Pharmaceutical Industries Ltd | N/A | $17.34B |
Frequently asked questions
What is Merck's PE ratio?
As of Apr 1, 2025, MRK stock has a price to earnings ratio of 12.89.
What is the 3-year average PE ratio for Merck (MRK)?
The average PE ratio for MRK stock over the past 3 years is 109.52.
What is the 5-year average PE ratio for Merck (MRK)?
The average PE ratio for MRK stock over the past 5 years is 73.15.
What is the highest PE ratio for MRK?
Over the last ten years, the quarterly PE ratio reached a historic high of 778.71 in the Dec 2023 quarter.
How does the current PE ratio for MRK compare to its historical average?
MRK's current price to earnings ratio is 77% below its 10-year historical average.
How is MRK's PE ratio calculated (Merck PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Apr 1, 2025), Merck's stock price is $87.12. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $6.76. Therefore, Merck's PE ratio for today is 12.89. PE RATIO(12.89) = STOCK PRICE($87.12) / TTM EPS($6.76)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.